Related Experiment Videos
Hantavirus infections and their prevention
D H Krüger1, R Ulrich, A Lundkvist A
1Institute of Virology, Humboldt University, School of Medicine Charité, D-10098, Berlin, Germany. detlev.kruger@charite.de
Microbes and Infection
|November 16, 2001
Summary
Hantaviruses, rodent-borne viruses, cause severe human diseases like haemorrhagic fever with renal syndrome and Hantavirus pulmonary syndrome. This review details their host interactions, clinical outcomes, diagnosis, and current therapeutic and vaccine development strategies.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- Hantaviruses are zoonotic viruses transmitted by rodents.
- They cause severe diseases in humans, including Hantavirus Pulmonary Syndrome (HPS) and Haemorrhagic Fever with Renal Syndrome (HFRS).
- Understanding hantavirus epidemiology and pathogenesis is crucial for public health.
Purpose of the Study:
- To provide a comprehensive review of hantavirus host interactions.
- To summarize the clinical manifestations and outcomes of human hantavirus infections.
- To discuss current prophylaxis, therapy, and vaccine development for hantaviral diseases.
Main Methods:
- Literature review of scientific publications on hantaviruses.
- Synthesis of information on rodent reservoirs and virus transmission.
- Analysis of data on human pathogenesis, diagnosis, and clinical management.
Main Results:
- Detailed overview of rodent reservoirs and their role in hantavirus transmission.
- Description of the pathogenesis and clinical spectrum of hantavirus infections in humans.
- Summary of current diagnostic methods and challenges.
- Assessment of existing therapeutic interventions and prophylaxis strategies.
Conclusions:
- Hantavirus infections pose a significant global health threat requiring continued research.
- Effective control strategies depend on understanding virus-host dynamics and transmission.
- Advancements in vaccine development are critical for preventing hantaviral diseases.